By Sindhu Sundar ( April 1, 2015, 7:06 PM EDT) -- The U.S. Food and Drug Administration on Wednesday finalized its guidance urging drugmakers to devise abuse-deterrent versions of opioid medications, a move that follows criticism by lawmakers and consumer groups about the agency's approval of Zogenix Inc.'s pure-hydrocodone painkiller Zohydro. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.